Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial

BACKGROUND: The aim of this trial was to evaluate the safety and efficacy of oral hydration as a substitute for intravenous hydration after cisplatin (CDDP) administration. METHODS: The major eligibility criteria included patients with lung cancer, indications for a CDDP-based regimen at a dose of 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Horinouchi, Hidehito, Kubota, Kaoru, Miyanaga, Akihiko, Nakamichi, Shinji, Seike, Masahiro, Gemma, Akihiko, Yamane, Yuki, Kurimoto, Futoshi, Sakai, Hiroshi, Kanda, Shintaro, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Tamura, Tomohide, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812393/
https://www.ncbi.nlm.nih.gov/pubmed/29503734
http://dx.doi.org/10.1136/esmoopen-2017-000288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812393/
https://www.ncbi.nlm.nih.gov/pubmed/29503734
http://dx.doi.org/10.1136/esmoopen-2017-000288

Ejemplares similares